← All companies

NNNN

Anbio Biotechnology

NNNN Nasdaq In Vitro & In Vivo Diagnostic Substances EDGAR ↗

$10.65

-0.10 -0.93%

Key statistics

from XBRL data in SEC filings

Market cap

$465M

Revenue (TTM)

$8.65M

Net income (TTM)

$6.40M

EPS (TTM)

$0.15

P/E ratio

72.4

Dividend yield

—

Free cash flow

—

Cash

$7.77M

Total assets

$30.2M

Gross margin

87.2%

52-week range

$8.30 – $54.95

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K May 19, 2026 6-K FORM 6-K Apr 27, 2026 20-F/A FORM 20-F/A1 Apr 9, 2026 20-F FORM 20-F Apr 7, 2026 6-K FORM 6-K Feb 17, 2026 6-K FORM 6-K Jan 26, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Dec 30, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Nov 13, 2025 20-F ANNUAL REPORT Apr 28, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Feb 21, 2025

Other filings

F-3ASR AUTOMATIC SHELF REGISTRATION STATEMENT OF SECURITIES OF WELL-KNOWN SEASONED ISSU Jul 9, 2026 3 Jun 12, 2026 3 Jun 12, 2026 3 Apr 8, 2026 3 Apr 8, 2026 3 Apr 8, 2026 3 Apr 8, 2026 3 Apr 8, 2026 424B4 PROSPECTUS Feb 19, 2025 EFFECT Feb 18, 2025 CERT Feb 18, 2025 CORRESP Feb 14, 2025 CORRESP Feb 14, 2025 8-A12B FOR REGISTRATION OF CERTAIN CLASSES Feb 14, 2025 F-1/A REGISTRATION STATEMENT Feb 10, 2025 F-1/A REGISTRATION STATEMENT Jan 24, 2025 FWP FREE WRITING PROSPECTUS Jan 22, 2025 F-1/A REGISTRATION STATEMENT Jan 10, 2025 F-1 REGISTRATION STATEMENT Dec 31, 2024 DRSLTR Dec 11, 2024 DRS/A Dec 11, 2024 UPLOAD Dec 4, 2024 DRS/A Nov 18, 2024 DRSLTR Jul 1, 2024 DRS/A Jul 1, 2024 UPLOAD Jun 21, 2024 DRS/A Jun 10, 2024 DRSLTR Jun 7, 2024 UPLOAD Mar 22, 2024 DRS/A Mar 11, 2024